ArticleAnnals of the rheumatic diseases2024

Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease.

Yusuke Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.